Tradestie Institutional Equity Comparison Engine

MESO vs EWTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EWTX Overall Edge

EWTX Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edgewise Therapeutics, Inc. Common Stock (EWTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus EWTX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against EWTX sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EWTX
MESO N/M vs EWTX N/M Fwd P/E
Growth & Margin Winner EWTX
Op Margin -42.6% vs 0.0% ยท YoY +390.7% vs +0.0%
Momentum & Technical Winner EWTX
1Y -16.4% vs +113.6% ยท 52W Pos 6% vs 82%
Options & Structure Winner EWTX
UNCLASSIFIED (37th %ile IV) vs CONSOLIDATION (17th %ile IV)
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
34.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0
EWTX NASDAQ
Edgewise Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$43.61
-5.05% 1D
Market Cap $5.0B
1M Return +17.26%
1Y Return +113.57%
Forward P/E N/M
Unified AI Score
33.6 / 100 SELL
Tech 8.0 Fund 38.0 Flow 66.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MESO -16.42% EWTX +113.57% Spread: +129.99 pp (EWTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MESO TTM Op. Margin: -42.6% EWTX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs EWTX. Trailing 12-month operating profitability (MESO -42.6% vs EWTX 0.0%) and valuation multiples (MESO N/M vs EWTX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MESO (2) vs EWTX (7)
Institutional Metric MESO EWTX Criterion Row Winner
Market Capitalization Scale $1.7B $5.0B Larger Scale EWTX
Trailing P/E Ratio Valuation N/M 5.5x Lower Multiple EWTX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +390.7% +0.0% Higher Growth MESO
Operating Margin (TTM) Profitability -42.6% 0.0% Higher Margin EWTX
Net Profit Margin Profitability -47.8% 0.0% Higher Margin EWTX
Return on Equity (ROE) Capital Efficiency -9.9% 92.1% Higher ROE EWTX
52-Week Range Position Momentum 6% ($12โ€“$22) 82% ($20โ€“$49) Stronger Trend EWTX
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 78% Vol 1.19ฮฒ ยท 74% Vol Lower Realized Risk EWTX
Unified Institutional Score Composite Signal 34.6 / 100 (SELL) 33.6 / 100 (SELL) Higher Composite MESO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MESO vs EWTX Buy Guide
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EWTX CONSOLIDATION
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live EWTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MESO nor EWTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.